GSK plc (GSK) は上場企業です ヘルスケア セクターの 製薬 業界で事業展開. 本社所在地は Brentford, イギリス. 現CEOは Luke Victor Miels.
GSK を有する IPO日 1980-03-28, 68,629 名の正社員, に上場 NYSE, 時価総額 $118.67B.
GSK plc is a global pharmaceutical and vaccine company headquartered in Brentford, United Kingdom, engaged in the research, development, and manufacture of vaccines and specialty medicines. The company's portfolio includes vaccines for shingles, meningitis, respiratory syncytial virus, influenza, and polio, as well as medicines for HIV, oncology, respiratory and immunology conditions, and antibiotics. GSK operates through Commercial Operations and Total R&D segments, serving markets across the United Kingdom, United States, and internationally. The company has established multiple strategic collaborations, including partnerships with CureVac for mRNA-based influenza vaccines, Wave Life Sciences for oligonucleotide platform development, and Flagship Pioneering for novel medicines and vaccines discovery. Founded in 1715 and rebranded as GSK plc in 2022, the company remains a leading player in global healthcare innovation.
